Stockscreener 앱 받기
10.34
25.44%
1.89
전일 마감가:
$8.45
열려 있는:
$11.31
하루 거래량:
8.63M
Relative Volume:
6.90
시가총액:
$14.96M
수익:
-
순이익/손실:
$-67.28M
주가수익비율:
-0.1092
EPS:
-94.66
순현금흐름:
$-9.80M
1주 성능:
+16.61%
1개월 성능:
+10.42%
6개월 성능:
+82.76%
1년 성능:
+120.65%
1일 변동 폭
$9.55
$11.51
1주일 범위
$8.11
$15.82
52주 변동 폭
$2.098
$23.01
Portage Biotech Inc Stock (PRTG) Company Profile
PRTG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRTG
Portage Biotech Inc
|
10.31 | 14.96M | 0 | -67.28M | -9.80M | -94.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.84 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
612.04 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
620.50 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
254.94 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
249.64 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Portage Biotech Inc Stock (PRTG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2022-03-07 | 개시 | H.C. Wainwright | Buy |
| 2021-09-21 | 개시 | Oppenheimer | Outperform |
| 2021-09-02 | 개시 | B. Riley Securities | Buy |
| 2021-08-19 | 개시 | Cantor Fitzgerald | Overweight |
Portage Biotech Inc 주식(PRTG)의 최신 뉴스
How analysts predict Portage Biotech Inc (PRTG) will perform this quarter? - uspostnews.com
Portage Biotech Stock Surges As It Prepares For Human Trial - Benzinga
Portage Biotech stock soars on promising preclinical results By Investing.com - Investing.com India
Portage Biotech’s PORT-7 shows efficacy in mesothelioma preclinical study - TipRanks
Insider Activity Signals Optimism for Portage Biotech (PRTG) - GuruFocus
Top Premarket Gainers - marketscreener.com
Portage Biotech Announces Preclinical Success for PORT-7 in Mesothelioma - TipRanks
Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7 - The Manila Times
New Cancer Drug Shows Superior Results: Mesothelioma Treatment Breakthrough Advances to Human Trials - Stock Titan
Insider Stock Buying Reaches US$2.15m On Portage Biotech - Yahoo Finance
Portage Biotech Inc (PRTG) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
PRTG Stock on the Rise: A Promising Investment - investchronicle.com
Short Interest in Portage Biotech Inc. (NASDAQ:PRTG) Rises By 2,134.8% - Defense World
SoftBank Group (OTCMKTS:SFTBF) Stock Crosses Below 200-Day Moving Average – What’s Next? - Defense World
iAnthus Capital Holdings, Inc. (OTCMKTS:ITHUF) Short Interest Up 2,600.0% in March - Defense World
Corning Natural Gas (OTCMKTS:CNIG) Shares Pass Below 200-Day Moving Average – Here’s What Happened - Defense World
Scorpio Gold (OTCMKTS:SRCRF) Share Price Crosses Below 200 Day Moving Average – What’s Next? - Defense World
Portage Biotech (PRTG) Resumes Key Clinical Trial Phase - GuruFocus
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Nasdaq Gains Over 50 Points; JPMorgan Posts Upbeat Earnings - Benzinga
Exec Edge Launches Research Coverage with Initiation Notes on FLD, CLYM, STKS, REX - Yahoo Finance
CVS Health Corporation (CVS): A Bull Case Theory - Yahoo Finance
Biotech CEOs, VCs urge Cassidy, Senate to ease impact of FDA cuts - Yahoo Finance
ImmunityBio, Inc. (IBRX): Among Stocks Under $10 that Will Triple - Yahoo Finance
Cannara Biotech Inc.'s (CVE:LOVE) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - Yahoo Finance
Augustine Therapeutics appoints Industry Veteran Pascale Witz as Chair of its Board of Directors - Yahoo Finance
General Oncology Appoints Seasoned Biotech Executive Abid Ansari as Chief Financial Officer - Yahoo Finance
Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Small Cap Stocks To Add to Your WatchlistMarch 29th - MarketBeat
Pre-market Movers: ICCT, CTOR, PCVX, AIM... - RTTNews
Portage Biotech’s After-Hours Surge On Preclinical Tumor Trial Data Sends Retail Optimism Sky-High - Asianet Newsable
Portage Biotech Insider Buyers See Boost After Market Cap Rose US$9.0m - simplywall.st
Promising Biotech Stocks To Watch Now – March 28th - Defense World
Portage Biotech (NASDAQ:PRTG) vs. Cytokinetics (NASDAQ:CYTK) Head-To-Head Survey - Defense World
Biotech Firms Celebrate Gains With Promising Trials And Partnerships - Finimize
Satellos Bioscience (TSE:MSCL) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Why Is Portage Biotech Stock Skyrocketing Friday? - Benzinga
Dow Tumbles Over 500 Points; Abacus Global Management Shares Spike Higher - Benzinga
Nasdaq Down 100 Points; Federal Reserve's Favorite Inflation Gauge Increases More Than Expected - Benzinga
Pre-market Movers: PRTG, RNAZ, PTIX, LGMK... - RTTNews
Portage Biotech (PRTG) Shares Skyrocket In Pre-Hour Trading - Stocks Telegraph
Why Braze Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Benzinga
PRTG Soars On Mesothelioma Data, NVNO Awaits FDA Decision, CureVac Jumps On Patent News - RTTNews
Portage Biotech Shares Jump Premarket After 'Promising' Preclinical Results in Mesothelioma - Marketscreener.com
Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7 - The Manila Times
Portage Biotech presents preclinical data for PORT-7 - TipRanks
Portage Biotech reports promising mesothelioma treatment data By Investing.com - Investing.com Australia
Portage Reports 'Promising' Preclinical Results in Mesothelioma - MarketScreener
Portage Biotech Announces Promising Preclinical Results for PORT-7 in Mesothelioma - TipRanks
Portage Biotech Inc (PRTG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.63%
자본화:
|
볼륨(24시간):